Shares of Cephalon are down on fears that growth of its sleep disorder drug Provigil is slowing and could be hurt by the early rollout of generics
More...
Toggle signature
||||| Mentor Group Access Now! |||||
More...
Toggle signature
||||| Mentor Group Access Now! |||||